AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Press Release: Barr receives approval for generic Prozac 10 mg tablets; company will launch immediately.

Chemical Business Newsbase

| February 04, 2002 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Barr Laboratories Inc announced on 4 Feb 2002 that the company has received approval from the US Food & Drug Administration for fluoxetine tablets 10 mg, the generic equivalent of Lilly's Prozac tablets. The company expects to launch the product immediately. Fluoxetine tablets 10 mg is indicated for the treatment of depression and for the treatment of obsessions and compulsions in patients with …

Related articles from newspapers, magazines, journals, and more
PRESS RELEASE: Lannett Co receives FDA approval for Isoniazid 300 mg tablets.
News wire article from: Chemical Business Newsbase December 4, 2001 700+ words
PRESS RELEASE: Lannett Co receives FDA approval for Primidone 50 mg Tablets.
News wire article from: Chemical Business Newsbase June 5, 2001 700+ words
Press Release: Ranbaxy announces receiving tentative approval from the US FDA...
News wire article from: Chemical Business Newsbase January 11, 2002 700+ words
Press Release: Alpharma receives USA FDA tentative approval for lisinopril 20...
News wire article from: Chemical Business Newsbase March 12, 2002 700+ words
Press Release: Alpharma receives USA FDA tentative approval for lisinopril...
News wire article from: Chemical Business Newsbase January 24, 2002 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily